Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

50 results about "Joint synovial" patented technology

Glucosamine composite tablets and preparation method thereof

The present invention discloses glucosamine composite tablets and a preparation method thereof, and belongs to the field of purposes of health food. On the basis of combination of glucosamine and calcium supplements, the glucosamine complex tablets further comprise active ingredients comprising the following materials: 100 to 400 parts of chondroitin sulfate, 100 to 400 parts of dimethyl sulfone, 100 to 400 parts of collagen, 1 to 40 parts of olive oil, 1 to 5 parts of sodium hyaluronate, and other auxiliary materials which comprise the following materials: 1 to 5 parts of a glidant, 1 to 5 parts of a lubricant and 1 to 10 parts of a coating premix agent. A mineral premix agent includes 1 to 5 parts of a boron agent, 1 to 5 parts of a manganese agent and 1 to 5 parts of a copper agent. The glucosamine complex tablets are further added with active ingredients with effects of enhancing cartilage, joint synovial fluid and bone density. The preparation method of the glucosamine complex tablets adopts a wet granulation process, and adequately overcomes problems of single product efficacy, low absorption and utilization rate in conventional glucosamine type health food.
Owner:JIANGSU ALAND NOURISHMENT

Food composition beneficial to bone health

PendingCN106620659ACompensation for bone damageCompensate for joint wear and tearSugar food ingredientsPeptide/protein ingredientsJoint synovialBones joints
The invention provides a food composition beneficial to the bone health. The food composition is characterized by containing the following components in parts by weight: 1-5 parts of a cockscomb extract, 1-3 parts of non-degenerated type II collagen, 1-3 parts of vitamin K2 and 5-10 parts of micro-activated curcumin. The food composition provided by the invention has the following technical effects: (1) by adding joint synovia, bone injuries such as joint wear and bone spurs caused due to the loss of synovial are avoided; (2) by adding anti-inflammatory molecules, the arthritis paint is relieved, the degradation reaction of cartilages is reduced, and the long-term health of bone joints is promoted; (3) the osteoporosis is prevented, the fracture risk is reduced, a strong skeleton network is constructed, the concentration of blood calcium is reduced, and and cardiovascular calcification is prevented; and (4) by combining the cockscomb extract, the non-degenerated type II collagen and the curcumin for use, the joint synovial is supplemented, meanwhile, the inflammatory reaction is reduced, and the arthralgia can be prevented; and by adding the vitamin K2, the osteoporosis of middle aged and elderly people can be prevented.
Owner:江苏中雍红瑞制药有限公司

Health care product for adjuvant treatment of osteoarticular diseases and preparation method of health care product

The invention relates to the technical field of health care medicine, and particularly discloses a health care product for the adjuvant treatment of osteoarticular diseases and a preparation method of the health care product. The health care product is mainly prepared by the following raw materials in parts by weight: 355 to 395 parts of glucosamine hydrochloride, 110 to 150 parts of chondroitin sulfate, 280 to 320 parts of calcium carbonate, 110 to 150 parts of fish collagen protein, 18 to 22 parts of a disintegrating agent, 36 to 44 parts of a binding agent, and 3 to 7 parts of a lubricant. The health care product is simple in formula, can effectively repair cartilage and improve bone mineral density, meanwhile dredge bone joints to promote blood microcirculation, expedite secretion of joint synovial fluid, eliminate adverse factors, diminish inflammation and alleviate pain, and effectively improve bone joint damage and reduce the problem of joint pain, is stable in product quality, convenient to take, safe and effective, does not have toxic and side effects, and can be taken for a long time. The preparation method is simple to operate, and suitable for industrialized promotion and application.
Owner:南京邦康生物技术有限公司

A pharmaceutical composition for preventing and treating arthritis and its preparation method

The invention discloses a pharmaceutical composition for preventing and treating arthritis, which is a preparation prepared from the following raw materials: selenium-containing inorganic compounds and zinc-containing inorganic compounds. The pharmaceutical composition can be prepared as an external preparation, which provides a faster and safer treatment method for various joint pains. Drug efficacy experiments prove that the pharmaceutical composition of the present invention can significantly reduce the level of inflammatory cytokines in the joint washing fluid of the arthritis model, and its ointment can even achieve better curative effect than Voltaren ointment, and has good clinical application prospect.
Owner:成都安普诺生物科技有限公司

Bone health product

The invention provides a bone health product, which comprises collagen, glucosamine, vitamin and zinc source. The provided bone health product organically combines the collagen, glucosamine, vitamin and zinc source together, thereby the absorption is easy; the production of proteoglycan and collagen in human body can be promoted for supplementing the joint synovial fluid, and the necessary material of cartilage tissue for recovering the health after the joint is injured can be provided, the collagen formation is promoted, calcareous absorption and production can be promoted, and the bone health product is helpful for health care effect to human bone.
Owner:邱多福

Preparation method and application of angiogenesis model

The invention provides a preparation method and application of an angiogenesis model. The method includes the following steps that firstly, vascular endothelial cells are inoculated to matrigel to primarily form vasoganglion; secondly, type I collagen is added to stimulate secondary angiogenesis. The preparation method is suitable for simulating the pathogenesis process of angiogenesis in joint synovial tissue and particularly suitable for simulating and building angiogenesis conditions in temporo-mandibular joint synovial tissue of a human body, and provides a new platform for research of action modes of new cytokines in the aspect of angiogenesis promotion or inhibition. The model is simple in manufacturing material and short in consumed time and has good development, expansion and tissue engineering application prospects.
Owner:WUHAN UNIV

Application of cobra venom or extract thereof to preparation of medicament for reducing uric acid and/or resisting to gouty arthritis

The invention relates to the field of medicine, and particularly provides application of cobra venom or an extract thereof to preparation of a medicament for reducing uric acid and / or resisting to gouty arthritis. According to the invention, the cobra venom can effectively reduce the blood uric acid level of a hyperuricemic mouse, meanwhile, has an obvious improvement effect on the gouty arthritis, and can repair the joint injury caused by sodium urate deposition, reduce the joint swelling rate, improve the joint synovial tissue thickening condition, reduce inflammatory cell infiltration, protect cartilage cells; and clinical experiments show that cobra neurotoxin can quickly eliminate subcutaneous gout calculi of gout patients, lumps disappear after the cobra venom is injected into the patients for three days, and no side effect exists. In conclusion, the Chinese cobra venom has the effect of repairing gouty arthritis while reducing uric acid, and can be used as a medicament for treating gout.
Owner:SUZHOU RENBEN PHARMA

Diagnostic marker of rheumatoid arthritis and application thereof

The invention provides the use of an antibody reactive with RNase L or a fragment thereof for the preparation of a medicament for diagnosing a rheumatoid arthritis (RA) disease. The invention also provides the use of a ribonuclease L gene as a biomarker for the preparation of a medicament for diagnosing a rheumatoid arthritis disease. The RNase L is significantly highly expressed in the joint synovial membrane of a RA patient and is positively correlated with the secretion of TNF[alpha]. After RNase L gene knockout, a CIA mouse model incidence and arthritis score are significantly inhibited. The above results confirm that the RNase L promotes the occurrence and development of the RA. The RNase L is mainly expressed in macrophages, and promotes the differentiation of macrophages into proinflammatory M1 by activating a JAK / STAT1 pathway, thereby promoting a RA inflammatory response. In summary, the RNase L can be used as a biomarker of the rheumatoid arthritis diseases.
Owner:INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI

Preparation method of hairtail active extract for repairing bone joints

The invention discloses a preparation method of hairtail active extract for repairing bone joints; the preparation method comprises the steps of enzyme complex hydrolysis, multistage membrane filtration, nanofiltration, HPLC (high-performance liquid chromatography) eluting and lyophilizing; the step of enzyme complex hydrolysis includes enzymatically hydrolyzing hairtail flesh homogenate via Bacillus marinus alkali-producing proteinase and Porphyra yezoensis proteinase, and performing ultrasonic-assisted enzymatic hydrolysis. The preparation method has the advantages that marine organism proteins are greatly differed from terrestrial life proteins in both amino acid composition and amino acid sequence and hairtail proteins can be enzymatically hydrolyzed via the Bacillus marinus alkali-producing proteinase and Porphyra yezoensis proteinase to obtain mass active peptides; the obtained hairtail active extract can promote the generation of cartilage cells, joint synovial fluid can be massively induced and supplemented, the generation of collagen matrix can be effectively promoted, regeneration of connective tissue cells is stimulated, and the reconstruction and recovery of soft tissues are accelerated accordingly.
Owner:兰溪市捷喜食品加工技术有限公司

Preparation method and application of noninvasive dermal penetration technology transdermal absorbent containing traditional Chinese medicine effective components

The invention discloses a preparation method and application of a noninvasive dermal penetration technology transdermal absorbent containing traditional Chinese medicine effective components. The transdermal absorbent comprises the following active ingredients: cortex dictamni, lumbricus, semen strychni and flos daturae extracts, an absorption transdermal patch is prepared, and the transdermal patch is stored through hair follicles. The traditional Chinese medicine transdermal absorbent has the advantages of avoiding the first-pass effect, inactivating gastrointestinal tracts, reducing the individual difference of medication and the like of a common transdermal preparation, also can achieve a long-acting slow release effect, and can maintain constant drug effect blood concentration and physiological effect within a certain time, and the cortex dictamni, the earthworm, the semen strychni and the flos daturae extract have anti-inflammatory and analgesic effects. The joint synovial tissue hyperplasia can be relieved, and the effects can be achieved in multiple aspects to treat arthritis.
Owner:HARBIN VOCATIONAL & TECHN COLLEGE

Cortex zanthoxyli total alkaloid extract and preparations as well as application thereof

The invention provides a cortex zanthoxyli total alkaloid extract and preparations as well as application thereof. The cortex zanthoxyli total alkaloid extract is obtained by extraction from the traditional Chinese medicine cortex zanthoxyli, and refining, wherein the total alkaloid content is basically more than 50%, and is up to 100% in maximum. The invention further provides preparations and medical application of the cortex zanthoxyli total alkaloid extract, wherein the preparations include powder injection, dropping pills, tablets, capsules, granules, and so on. Pharmacodynamic and toxicology tests prove that the cortex zanthoxyli total alkaloid extrac can remarkably restrain proliferation of CIA (Collagen Induced Arthritis) rat joint synovial cells, and has low toxic and side effects.
Owner:HUNAN UNIV OF CHINESE MEDICINE

Essential oil for relieving rheumatoid arthritis

InactiveCN113521171AAntipyreticAnalgesicsJoint synovialSynovial Cell
The invention relates to the technical field of essential oil, in particular to essential oil for relieving rheumatoid arthritis; the essential oil comprises various natural plant components such as Zhejiang wintersweet essential oil, rhizoma acori graminei essential oil, frankincense essential oil, litsea cubeba essential oil and fir essential oil, and is characterized in that a TNF-alpha, CCK-8 method and ELISA are utilized to act on MH7A cells to construct a joint fibroblast synovial cell inflammation model. The effect of the essential oil on joint synovial membranes is simulated, the influence of the essential oil with different concentrations on human mast cells LAD2 is measured through a CCK-8 method and C48 / 80, the influence of the essential oil on an immune system is simulated, the result shows that the essential oil has the positive effect on joint synovial membrane inflammation and immune cell function disorder, and the essential oil has practical significance and popularization value; the essential oil can be used for developing products for relieving rheumatoid arthritis.
Owner:福建香缘生物科技发展有限公司

Application of joint synovial fluid biomarker ADAMDEC1

The invention discloses a joint synovial fluid biomarker ADAMDEC1 and an application of a detection product of the joint synovial fluid biomarker ADAMDEC1 in diagnosis and differentiation of two diseases including rheumatoid arthritis and osteoarthritis. The biomarker ADAMDEC1 has a very high diagnostic value in the aspect of diagnosing and distinguishing rheumatoid arthritis and osteoarthritis, is high in diagnostic accuracy, more directly aims at local focuses compared with an existing diagnostic standard, and is easy to operate.
Owner:东阳市人民医院

Pharmaceutical preparation of macrophage-derived exosome loaded aconite decoction extract, preparation method and application thereof in preparation of drugs for preventing and treating osteoarthritis

PendingCN123024048AJoint synovialIn vitro test
The present application relates to the fields of medicine, modernization of traditional Chinese medicine and drug delivery, and specifically relates to a macrophage-derived exosome loaded with aconite decoction extract, a preparation method thereof and application thereof in preparation of a drug for preventing and treating osteoarthritis. The effective component of the drug preparation is macrophage-derived exosome loaded with aconite decoction extract, which includes low-loading preparation WTDL-Exos and high-loading preparation WTDH-Exos and contains pharmaceutically acceptable excipients. The macrophage-derived exosome is preferably derived from mouse macrophage RAW264.7 and is extracted through differential centrifugation and ultracentrifugation; the aconite decoction extract is prepared from prepared monkshood, astragalus, honeyed licorice, ephedra and peony, and the concentration of the aconite decoction mother liquor is 10 mg / mL; the drug-loaded exosome is obtained by co-incubation of the aconite decoction extract and the macrophage-derived exosome and purification, and the loading rate is about 20%. In vitro tests show that WTD-Exos has no obvious effect on cell survival rate and is basically non-cytotoxic. Western blot detection in animal experiments shows that the drug preparation can down-regulate the expression of MMP-13 and TNF-α in synovial tissue and up-regulate the expression of type II collagen, thereby improving joint synovial inflammation and protecting joint cartilage. The drug preparation can be used for preparing a drug for preventing and treating osteoarthritis.
Owner:CHONGQING MEDICAL UNIVERSITY

Hydrogel composition for intra-articular administration and use thereof

PCT designated stageWO2026034949A1Organic active ingredientsSkeletal disorderJoint synovialIntraarticular Injections
The present invention relates to a hydrogel composition for intra-articular administration, which is easily injected into the human body, and use thereof for supplementing joint synovial fluid, supplementing viscosity, and preventing or treating intra-articular lesions. The hydrogel composition according to the present invention can improve the gelation temperature, viscosity, biodegradability, and tissue support capability of hyaluronic acid and, at the same time, can improve practitioner convenience and patient compliance due to the reduced injection pressure thereof. In addition, the hydrogel composition can increase the effect of ameliorating intra-articular lesions when co-administered with stem cells or exosomes, and thus can have various applications in medical devices and pharmaceutical fields for the purpose of cartilage regeneration and intra-articular lesion treatment.
Owner:PLACEUTICALS CO LTD

Joint synovial ablation flexible focusing ultrasonic transducer and dynamic compensation method thereof

The invention belongs to the technical field of ultrasonic transducer focusing, and provides a joint synovial membrane ablation flexible focusing ultrasonic transducer and a dynamic compensation method thereof.The ultrasonic transducer comprises a sensing wafer unit and a phased array control unit, and each sensing wafer can independently move relatively to adapt to the shape of the joint skin contour; the phased array control unit controls the excitation time and the excitation sequence of each sensing wafer through a focusing rule so as to control the deflection angle and the focusing depth of a finally synthesized ultrasonic wave beam, so that the ultrasonic wave beam is deflected and focused to a target focus area; the dynamic compensation method comprises the following steps: acquiring a displacement value of each displacement sensor; calculating the relative displacement of each sensing wafer; calculating ultrasonic transmission time corresponding to the relative displacement of each sensing wafer as a focusing rule time correction value; and superposing the focusing rule time correction value into a control time function of the focusing rule to complete dynamic compensation of the joint synovial membrane ablation flexible focusing ultrasonic transducer.
Owner:SICHUAN UNIV +1

Hip joint prosthesis with bionic joint capsule and application

The invention relates to the technical field of medical prostheses, in particular to a hip joint prosthesis with a bionic joint capsule and application of the hip joint prosthesis with the bionic joint capsule. A joint sliding capsule is additionally arranged between an acetabular cup and a femoral stem, so that the acetabular cup and the femoral stem can be stably and reliably connected, and ball socket stability is provided for initial postoperative recovery; meanwhile, mechanical support can be provided for tissue repair, and fusion of ligament and joint capsule soft tissue is promoted; the joint slide bag is of a porous structure, external tissue fluid flows in, is stored and is lubricated through the porous structure, and direct contact between friction pairs is reduced, so that the friction coefficient is reduced, and the wear resistance of the prosthesis is improved.
Owner:SHAANXI UNIV OF SCI & TECH

Application of Chinese medicine composition in preparing medicine for preventing and treating gouty arthritis

The present invention provides an application of a Chinese medicine composition in the preparation of a medicine for preventing and treating gouty arthritis; the Chinese medicine composition comprises the following active ingredients: bupleurum, ganoderma lucidum, salvia miltiorrhiza, and schisandra chinensis. The present invention verifies through animal experiments that the above-mentioned Chinese medicine composition has a certain inhibitory effect on inflammatory factors in serum and has a relieving effect on the pain of rats with acute gouty arthritis. It can improve the joint swelling of rats with acute gouty arthritis, significantly reduce the level of inflammatory factors in rat serum, relieve the pain of rats, and improve the infiltration of inflammatory cells in the synovial tissue of the joints, indicating that the above-mentioned Chinese medicine composition has a certain anti-inflammatory and analgesic effect on acute gouty arthritis.
Owner:TSING HUA DE REN XIAN HAPPINESS PHARMA

Traditional Chinese medicine composition for treating joint bursitis, synovitis and arthritis and preparation and application thereof

The invention belongs to the field of traditional Chinese medicine technical research, and particularly relates to a traditional Chinese medicine composition for treating joint bursitis, synovitis andarthritis and preparation and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials: rhizoma arisaematis, rhizoma bletillae, radix sophorae subprostratae, radix paeoniae rubra, fructus gleditsiae, Chinese cinnamon, clematis chinensis, cortex erythrinae, yam rhizome, pangolin scales, cortex phellodendri, radix stephaniae tetrandrae, radix achyranthis bidentatae, rhizoma alismatis, oysters and castor leaves. The traditional Chinese medicine composition can be mainly used for treating joint bursitis, synovitis and arthritis and other symptoms.
Owner:重庆涪陵李志沧中医骨伤医院有限公司

Sleep-aiding pomegranate wine

The invention discloses a sleep-aiding pomegranate wine. The pomegranate juice wine is prepared from the following components through three times of gradient fermentation and blending: pomegranate juice primary fermented wine with the volume ratio of 60 + / -2%, the alcoholic strength of 8-9% vol and the fermentation temperature of 1-3 DEG C; the pomegranate rind processing wine has a volume ratio of 10 + / -1%, the pomegranate rind is processed by a traditional Chinese medicine processing technology, and then low-temperature extraction is carried out at an extraction temperature of less than or equal to 50 DEG C; flavonoid compounds (such as quercetin and kaempferol) in pomegranate seeds can inhibit the activity of epoxidase-2 (COX-2) and reduce the release of inflammatory factors such as prostaglandin E2 (PGE2) (experimental data: the inhibition rate is greater than or equal to 65%); vitamin C and polyphenol cooperate to promote joint synovial cells to secrete hyaluronic acid, the viscoelasticity of the joint lubricating fluid is improved (the viscosity is increased by 30%), and the pain of osteoarthritis is relieved.
Owner:马全福

Joint synovial cavity endoscope device

The invention relates to the technical field of endoscopes, in particular to a joint synovial cavity endoscope device which comprises an outer shell, a grab handle, a supporting pad, a driving part, a moving plate, an adjusting part, a connecting rod, an adjusting plate, a micro camera and a light source system. The connecting rod is driven by the adjusting piece to rotate along the axis of the connecting rod, so that the adjusting plate can be driven to rotate along the axis of the connecting rod, and then the micro camera and the light source system can be driven to rotate along the axis of the connecting rod. The angle of the micro camera is adjusted, the micro camera can observe the diseased region of a patient in all directions by adjusting the position and the angle of the micro camera, and therefore medical staff can obtain a more comprehensive operation view field, and the use effect of the endoscope is improved.
Owner:LUKA (CHONGQING) MEDICAL EQUIP CO LTD

Pet anti-aging additive based on compound functional components and preparation method of pet anti-aging additive

The invention provides a pet anti-aging additive based on compound functional components and a preparation method thereof, and relates to the technical field of pet foods.The additive takes arabinoxylan, micrococcus oil and nano traditional Chinese medicine extracts as matrixes to construct a multi-dimensional anti-inflammatory barrier system, and the multi-dimensional anti-inflammatory barrier system is prepared into the pet anti-aging additive based on the compound functional components. The proanthocyanidins and the micrococcus oil are adopted to form a neuroprotection synergistic interaction system, and meanwhile, a microencapsulation process is combined, so that the bioavailability is improved, and a multi-dimensional anti-aging mechanism of resisting oxidation, regulating and controlling senescence-related markers and resisting inflammation is realized; in-vitro experiments show that the additive can effectively inhibit the expression of SA-beta-gal in canine fibroblasts, and can reduce the MDA content and relieve oxidative damage by improving the activity of SOD and GSH-Px; in-vivo experiments show that the additive can effectively reduce the CCDR score of a test dog, obviously improve the cognitive function of the test dog, improve the NAD + level of plasma, reduce the levels of TNF-alpha, IL-1beta and IL-6 in joint synovial fluid and exert the anti-aging effect, and a safe and efficient new scheme is provided for delaying pet aging.
Owner:HENAN UNIV OF ANIMAL HUSBANDRY & ECONOMY

Application of rotigotine microspheres in preparation of medicine for preventing and treating rheumatoid arthritis

The invention discloses an application of rotigotine microspheres in preparation of medicines for preventing or treating rheumatic arthritis, the rotigotine microspheres can directly act on joint parts, joint synovial hyperplasia, joint injury and bone erosion are effectively reduced, and the curative effect of the rotigotine microspheres is improved. The rotigotine microspheres can be independently used or matched with other known medicines, compounds or carriers to be prepared into various forms of medicaments or pharmaceutical compositions for prevention or treatment, and the dopamine receptor can be continuously excited for 4-8 weeks by injecting once during administration, so that the'on-off 'phenomenon caused by fluctuation of blood concentration is remarkably improved, and the bioavailability of the rotigotine microspheres is improved. Therefore, the curative effect can be effectively improved, and the compliance of a patient is greatly improved.
Owner:YANTAI UNIV

Butyl-glycine cross-linked sodium hyaluronate gel as well as composition and preparation method thereof

The invention discloses a butyl-glycine cross-linked sodium hyaluronate gel and a composition and a preparation method thereof. The cross-linked sodium hyaluronate gel is a gel mixture formed by swelling gel of cross-linked hyaluronic acid and salt thereof in a sodium chloride phosphate physiological buffer solution, wherein the gel of the cross-linked hyaluronic acid and the salt thereof is prepared by cross-linking the hyaluronic acid or the salt thereof with a cross-linking agent; wherein the D50 particle size distribution range of the gel mixture is 300-3000 [mu] m, so that the gel mixture can better simulate the physical characteristics of healthy joint synovial fluid and provide more effective lubricating and buffering effects under the condition of the same gel molecular weight and energy storage elastic modulus, thereby relieving joint friction and pain and improving the curative effect of cross-linked sodium hyaluronate maintained in vivo.
Owner:SHAANXI LICAI GROUP XIANYANG LICAI MEDICAL

Method for inducing ankylosing spondylitis synovial fibroblast osteogenesis in vitro

The invention provides a method for inducing ankylosing spondylitis synovial fibroblast osteogenesis in vitro, and belongs to the technical field of cell culture, the ankylosing spondylitis hip joint synovial fibroblast is induced in vitro by using 100ng / mL of tumor necrosis factor-alpha (TNF-alpha) and 100ng / mL of bone morphogenetic protein 2 (BMP-2), and the ankylosing spondylitis hip joint synovial fibroblast can be converted into osteoblasts 12 days after induction. The ankylosing spondylitis synovial fibroblast osteogenesis is specifically induced, the interference of non-target cells is reduced, and the accuracy and reliability of the experiment are improved; the method disclosed by the invention is simple, strong in operability and good in controllability, lays a foundation for research on pathogenesis of new bone formation of ankylosing spondylitis, can greatly shorten the experimental period, and has better application prospects compared with traditional BMP-2 and TGF-beta induced fibroblasts. The osteogenesis model constructed by the method is closer to an osteogenesis mechanism of ankylosing spondylitis and is higher in conversion efficiency.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Application of pigmented villus nodular synovitis differential tissue protein and / or metabolite and kit

The invention discloses application of pigmented villus nodular synovitis differential tissue proteins and / or metabolites and a kit. The differential tissue protein at least comprises one of the following proteins: TNFSF11, cathepsin K and an adhesion G protein coupled receptor E5; the differential metabolites at least comprise one of the following products: 13-hydroxylinoleic acid peroxide and octadecadienoic acid; according to the invention, the novel PVNS screening marker for the pigmented villus nodular synovitis is provided through proteomics and metabonomics, so that the effective screening of the pigmented villus nodular synovitis can be realized; the obtained screening marker is used for a screening kit, screening and detection can be rapidly carried out only by taking joint synovial fluid as a detection sample, and the method has the advantages of high efficiency, simple detection and the like.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV